Cessatech is a pivotal-stage paediatric biotech company developing first-in-class specialty hospital medicines for children, focused on high-impact unmet needs in acute and emergency care. The company’s lead program, CT001, is advancing toward near-term commercialization. Cessatech operates a capital-efficient, partnership-driven model, combining a lean, experienced team with best-in-class partners for development, manufacturing and commercial execution across key markets. Headquartered in Hellerup, Denmark, Cessatech is led by a seasoned leadership team with a strong track record in drug development and product launches in Europe, the US and Asia.
| Website | http://www.cessatech.com |
| Employees | 8 (5 on RocketReach) |
| Address | 2 Kanonbådsvej, Copenhagen, Capital Region of Denmark DK-1437, DK |
| Technologies |
JavaScript
,
HTML
,
PHP
+19 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing, Pharmaceuticals, Healthcare |
| Keywords | Evidence Based Medicine, Pediatric Medicine, Child Health, Clinical Research, Pharmaceutical Research, Clinical Trials, Precision Medicine, Drug Development, Therapeutic Solutions, Drug Discovery, Rare Diseases, Medical Technology, Biotechnology, Health Technology Assessment, Scientific Research, Healthcare Innovation, Orphan Drugs, Medical Devices, Pediatric Oncology, Patient Care |
| Competitors | Johnson & Johnson, Roche, Novartis, Merck AH, Pfizer, Bayer, AstraZeneca, Bristol Myers Squibb, Amgen, Gilead Sciences +41 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular Cessatech A/S employee's phone or email?
Jes Trygved is the CEO of Cessatech A/S.
5 people are employed at Cessatech A/S.
Cessatech A/S is based in Copenhagen, Capital Region of Denmark.
The NAICS codes for Cessatech A/S are [32, 325].
The SIC codes for Cessatech A/S are [28, 283].